Lv11
56 积分 2025-09-03 加入
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study
8分钟前
已完结
Multimonth dispensing of antiretroviral therapy for HIV
13分钟前
求助中
Efficacy of dolutegravir plus lamivudine in treatment-naive people living with HIV without baseline drug-resistance testing available (D2ARLING): 48-week results of a phase 4, randomised, open-label, non-inferiority trial
2天前
已完结
Development and Evaluation of a Nomogram for Predicting the Outcome of Immune Reconstitution Among HIV/AIDS Patients Receiving Antiretroviral Therapy in China
28天前
已完结
Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensus
4个月前
已关闭
Development and Evaluation of a Nomogram for Predicting the Outcome of Immune Reconstitution Among HIV/AIDS Patients Receiving Antiretroviral Therapy in China
5个月前
已完结
Perceived changes in sexual experience after voluntary medical male circumcision among men who have sex with men
5个月前
已关闭
Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People With HIV
5个月前
已完结
A New Type of Nonsuppressible Viremia Produced by HIV-Infected Macrophage
5个月前
已关闭
Tuberculosis and HIV Coinfection: Advances and Remaining Concerns
7个月前
已关闭